Blood Cancer Drugs Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 25
SKU : PH3416
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Blood Cancer Drugs Market ?
Global Blood Cancer Drugs Market size reached USD 63 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 113.5 billion by 2031
Who are the Key Players of Blood Cancer Drugs Market?
Major players are Amgen Inc., AstraZeneca Plc, Takeda Pharmaceutical Company Ltd, Bayer AG, Celgene Corporation, Eli Lilly, Bristol-Myers Squibb Company, Gilead Sciences Inc., Daiichi Sankyo Company Ltd and UCB SA.
Related Reports
pharmaceuticals

Leukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 05
Starting from

$4350

pharmaceuticals

Cancer Stem Cell Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 21
Starting from

$4350

pharmaceuticals

Acute Lymphocytic Leukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350

pharmaceuticals

Cancer Angiogenesis Inhibitors Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 24
Starting from

$4350

pharmaceuticals

Skin Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 November 09
Starting from

$4350

pharmaceuticals

Non Melanoma Skin Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 01
Starting from

$4350